AI-Driven Prediction of Dialysis Outcome With EHR

NCT ID: NCT06791447

Last Updated: 2025-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for outcome of dialysis patients, leveraging multimodal health data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to develop an AI-assisted model to predict clinical outcomes in dialysis patients, focusing on both primary outcomes (e.g., mortality) and intermediate outcomes (e.g., anemia, blood pressure, nutritional status, and calcium-phosphate metabolism). The study will utilize patients' EHR data, including laboratory test results, medical history, dialysis treatment information, and clinical observations, to predict these health outcomes. The goal is to improve early identification of at-risk patients, enabling better clinical decision-making and personalized care strategies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dialysis Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Risk Group

Participants predicted to have a high risk of mortality based on AI-assisted prediction models using their EHR data, including medical history, lab results, dialysis treatment details, and clinical observations.

AI-assisted Predictive Model for Dialysis Outcomes

Intervention Type OTHER

This study utilizes an AI-assisted predictive model that analyzes multimodal data from electronic health records, including medical history, laboratory results, dialysis treatment details, and clinical observations, to predict outcomes for dialysis patients. The model employs deep learning algorithms to predict mortality risk, intermediate outcomes such as anemia, blood pressure control, nutrition, and calcium-phosphate metabolism, and helps identify early signs of deterioration. The intervention is not a direct treatment or procedure but aims to develop a tool for predicting patient outcomes and optimizing treatment strategies to improve overall health and survival rates for dialysis patients.

Low Risk Group

Participants predicted to have a low risk of mortality based on the AI-assisted prediction model, who will be compared with the high-risk group for evaluating the effectiveness of early intervention strategies.

AI-assisted Predictive Model for Dialysis Outcomes

Intervention Type OTHER

This study utilizes an AI-assisted predictive model that analyzes multimodal data from electronic health records, including medical history, laboratory results, dialysis treatment details, and clinical observations, to predict outcomes for dialysis patients. The model employs deep learning algorithms to predict mortality risk, intermediate outcomes such as anemia, blood pressure control, nutrition, and calcium-phosphate metabolism, and helps identify early signs of deterioration. The intervention is not a direct treatment or procedure but aims to develop a tool for predicting patient outcomes and optimizing treatment strategies to improve overall health and survival rates for dialysis patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AI-assisted Predictive Model for Dialysis Outcomes

This study utilizes an AI-assisted predictive model that analyzes multimodal data from electronic health records, including medical history, laboratory results, dialysis treatment details, and clinical observations, to predict outcomes for dialysis patients. The model employs deep learning algorithms to predict mortality risk, intermediate outcomes such as anemia, blood pressure control, nutrition, and calcium-phosphate metabolism, and helps identify early signs of deterioration. The intervention is not a direct treatment or procedure but aims to develop a tool for predicting patient outcomes and optimizing treatment strategies to improve overall health and survival rates for dialysis patients.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients who have been undergoing dialysis (either hemodialysis or peritoneal dialysis) for at least 3 months.
2. Complete and accessible EHR data, including medical history, laboratory test results, dialysis treatment details, and clinical observations.
3. Participants must provide informed consent for the use of their health data for research purposes.

Exclusion Criteria

1. Patients with incomplete or missing critical EHR data, including medical history, laboratory results, dialysis data, or treatment details necessary for the study.
2. Patients who have been on dialysis for less than 3 months, to ensure stable data for outcome prediction.
Minimum Eligible Age

20 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Eye Hospital of Wenzhou Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kang Zhang

Chief Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

General Hospital of PLA

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fei Liu, MD

Role: CONTACT

+86 13810512704

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Delong Zhao

Role: primary

+86 13810512704

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Dialysis

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preventing Early Dialysis Starts
NCT02183987 COMPLETED NA